These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10904772)

  • 1. [Genetic therapy in mucoviscidosis].
    Bellon G; Pavirani A
    Arch Pediatr; 2000 May; 7 Suppl 2():355s-357s. PubMed ID: 10904772
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 5. [Functional success follow-up in mucoviscidosis gene therapy].
    Kersting U
    Pneumologie; 1996 Dec; 50 Suppl 3():867-72. PubMed ID: 9157445
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Somatic gene transfer in hepatic cystic fibrosis?].
    Elsing C; Stremmel W
    Z Gastroenterol; 1995 Sep; 33(9):555-6. PubMed ID: 8525663
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 9. [From gene transfer to gene therapy in cystic fibrosis, how long is the road?].
    Bellon G
    Rev Prat; 1998 Jan; 48(1):5-8. PubMed ID: 9781203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy research in cystic fibrosis--lessons from early clinical studies].
    Coutelle C
    Pneumologie; 1996 Dec; 50 Suppl 3():865-6. PubMed ID: 9157444
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero.
    Larson JE; Morrow SL; Happel L; Sharp JF; Cohen JC
    Lancet; 1997 Mar; 349(9052):619-20. PubMed ID: 9057739
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy for cystic fibrosis: steady progress, should do well.
    Alton EW; Geddes DM
    Eur Respir J; 1997 Feb; 10(2):257-9. PubMed ID: 9042618
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for cystic fibrosis.
    Alton E; Smith S; Geddes D
    Lancet; 1997 Apr; 349(9060):1249-50. PubMed ID: 9130964
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for CF.
    Eubanks M
    Environ Health Perspect; 2001 Jan; 109(1):A16. PubMed ID: 11171534
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gene therapy of mucoviscidosis].
    Rochat T
    Rev Med Suisse Romande; 1996 May; 116(5):345-9. PubMed ID: 8693270
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospects of gene therapy in mucoviscidosis using viral infection of the airway epithelium].
    Bayle JY; Boucher RC
    Rev Mal Respir; 1994; 11(4):345-55. PubMed ID: 7526426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of cystic fibrosis and progress towards gene therapy.
    Stern M; Alton E
    J R Coll Physicians Lond; 1999; 33(5):434-9. PubMed ID: 10624657
    [No Abstract]   [Full Text] [Related]  

  • 19. Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.
    Crystal RG
    J Clin Invest; 1999 Dec; 104(11):1491-3. PubMed ID: 10587510
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.